Company Overview of APT Pharmaceuticals, Inc.
APT Pharmaceuticals, Inc. develops cyclosporine inhalation solution for the prevention of chronic rejection in lung transplantation. The company's cyclosporine inhalation solution is an inhaled formulation of cyclosporine A, an oral medication is used to prevent rejection in solid organ transplant recipients. The company was founded in 1999 and is based in Burlingame, California.
700 Airport Boulevard
Burlingame, CA 94010
Founded in 1999
Key Executives for APT Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Ablaris Therapeutics, Inc.||United States|
|Cydan Development, Inc.||United States|
|Advance Biofactures Corporation||United States|
|Chattem Chemicals, Inc.||United States|
|Meritage Pharma, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact APT Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.